Cancer Research UK

Cancer Research UK stands in London as the world’s largest independent cancer research organisation. It was formed in 2002 by the merger of two long-established charities, the Imperial Cancer Research Fund and The Cancer Research Campaign. The organisation conducts research through its own staff and grant-funded researchers across the UK. It also runs public information campaigns and policy work, funded almost entirely by donations and fundraising. Over 25,000 people regularly volunteer their time to support its work. The charity’s research covers over 100 cancer types, from basic laboratory studies to clinical trials involving more than a million people. It funds the work of over 4,000 researchers, doctors and nurses, and supports over 200 clinical trials. Its scientists have developed several widely used cancer drugs, including cisplatin, tamoxifen and abiraterone. Major prizes have been awarded to its researchers, such as Tomas Lindahl, who shared the 2015 Nobel Prize in Chemistry. The organisation also leads citizen-science projects like mobile games that help analyse genetic data. Visitors to Cancer Research UK find research institutes linked to universities in Cambridge, Glasgow, Manchester and London. These centres work closely with NHS hospitals and other partners. The charity also funds seven research networks across the UK, providing equipment and training to top-performing sites. Public engagement includes projects where volunteers help analyse cancer samples through web apps and games. The organisation’s work continues to shape treatment and policy, driven by donations and public support.